NCT02609451

Brief Summary

The purpose of this study is to compare the feasibility, safety, and quality of life (QOL) in patients (pts) undergoing protective ileostomy closure after 2 weeks with a closure after 12 weeks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

September 24, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
Last Updated

August 31, 2017

Status Verified

January 1, 2017

Enrollment Period

6.3 years

First QC Date

September 24, 2015

Last Update Submit

August 29, 2017

Conditions

Keywords

quality of lifefeasibilitysafetyprotective ileostomy closure

Outcome Measures

Primary Outcomes (1)

  • Quality Of Life (GQLI - Questionnaire)

    Quality Of Life Survey using the GQLI - Questionnaire

    6 weeks

Secondary Outcomes (4)

  • Feasibility (via Visual Analogue Scale)

    intraoperatively

  • Safety as assessed by Morbidity, Mortality

    6 weeks, 16 weeks

  • Quality Of Life (EORTC - Questionnaire)

    preoperative (preOP), 6 weeks, 16 weeks

  • Quality Of Life (GQLI - Questionnaire)

    preOP, 16 weeks

Study Arms (2)

2 weeks

EXPERIMENTAL

Ileostomy closure after 2 weeks

Procedure: Ileostomy closure

12 weeks

EXPERIMENTAL

Ileostomy closure after 12 weeks

Procedure: Ileostomy closure

Interventions

Ileostomy closure at a different time point

12 weeks2 weeks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • anastomosis ≤ 5cm from anal verge
  • age \>18 years
  • informed consent
  • uneventful course after first operation

You may not qualify if:

  • pregnancy
  • allergy to contrast agent
  • severe non-surgical complications
  • evident abdominal - pelvic complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kantonspital Baselland Liestal

Liestal, Basel-Landschaft, 4410, Switzerland

Location

Related Publications (4)

  • Thalheimer A, Bueter M, Kortuem M, Thiede A, Meyer D. Morbidity of temporary loop ileostomy in patients with colorectal cancer. Dis Colon Rectum. 2006 Jul;49(7):1011-7. doi: 10.1007/s10350-006-0541-2.

    PMID: 16598401BACKGROUND
  • O'Leary DP, Fide CJ, Foy C, Lucarotti ME. Quality of life after low anterior resection with total mesorectal excision and temporary loop ileostomy for rectal carcinoma. Br J Surg. 2001 Sep;88(9):1216-20. doi: 10.1046/j.0007-1323.2001.01862.x.

    PMID: 11531870BACKGROUND
  • Hallbook O, Matthiessen P, Leinskold T, Nystrom PO, Sjodahl R. Safety of the temporary loop ileostomy. Colorectal Dis. 2002 Sep;4(5):361-364. doi: 10.1046/j.1463-1318.2002.00398.x.

    PMID: 12780582BACKGROUND
  • Elsner AT, Brosi P, Walensi M, Uhlmann M, Egger B, Glaser C, Maurer CA. Closure of Temporary Ileostomy 2 Versus 12 Weeks After Rectal Resection for Cancer: A Word of Caution From a Prospective, Randomized Controlled Multicenter Trial. Dis Colon Rectum. 2021 Nov 1;64(11):1398-1406. doi: 10.1097/DCR.0000000000002182.

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Christoph A. Maurer, Prof.Dr.med.

    Cantonal Hosptal, Baselland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2015

First Posted

November 20, 2015

Study Start

November 1, 2007

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

August 31, 2017

Record last verified: 2017-01

Locations